This NICE technology appraisal guidance considers the clinical and cost effectiveness of the use of alteplase for acute ischaemic stroke.
No takes yet. Share an insight, caveat, or question.
Chung et al. (2007) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: